Skip to records

Therapeutics

229Aging Biotech
100 of 229 records

MSDC-160 (M160)

Source date not recordedAnalyse record ↗
Modality
small molecule
Kind
rate-of-aging
Tested by ITP
yes
ITP year first tested
2021
ITP median % ↑ (♂, best cohort)
8.70
ITP median % ↑ (♀, best cohort)
-2.30
ITP P90 % ↑ (♂, best cohort)
2.90
ITP P90 % ↑ (♀, best cohort)
-3.90
ITP sex effect
male
ITP dose (ppm)
300 ppm
ITP age at start (mo)
7 mo
ITP replicated
no
ITP result status
Published (full stats)

ITP cohort detail (1)

YearCohortDose♂ med♀ med♂ P90♀ P90Citation
2021C2021300 ppm8.7%-2.3%2.9%-3.9%↗ paper